Werewolf Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell HOWL and other ETFs, options, and stocks.About HOWL
Werewolf Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. The firm offers Predator Technology which focuses on immune targeting and activation.
CEODaniel J. Hicklin
CEODaniel J. Hicklin
Employees46
Employees46
HeadquartersWatertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded2017
Founded2017
Employees46
Employees46
HOWL Key Statistics
Market cap32.85M
Market cap32.85M
Price-Earnings ratio-0.41
Price-Earnings ratio-0.41
Dividend yield—
Dividend yield—
Average volume358.87K
Average volume358.87K
High today$0.6811
High today$0.6811
Low today$0.63
Low today$0.63
Open price$0.663
Open price$0.663
Volume113.70K
Volume113.70K
52 Week high$2.38
52 Week high$2.38
52 Week low$0.5301
52 Week low$0.5301
Stock Snapshot
As of today, Werewolf Therapeutics(HOWL) shares are valued at $0.68. The company's market cap stands at 32.85M, with a P/E ratio of -0.41.
On 2026-02-13, Werewolf Therapeutics(HOWL) stock traded between a low of $0.63 and a high of $0.68. Shares are currently priced at $0.68, which is +7.4% above the low and -0.6% below the high.
Werewolf Therapeutics(HOWL) shares are trading with a volume of 113.7K, against a daily average of 358.87K.
In the last year, Werewolf Therapeutics(HOWL) shares hit a 52-week high of $2.38 and a 52-week low of $0.53.
In the last year, Werewolf Therapeutics(HOWL) shares hit a 52-week high of $2.38 and a 52-week low of $0.53.
People also own
Based on the portfolios of people who own HOWL. This list is generated using Robinhood data, and it’s not a recommendation.